Canadian Scientists Identify Chromosome Linked to Colorectal Cancer
Researchers at the Ontario Institute for Cancer Research have identified a genetic variation on chromosome 8 associated with colorectal cancer.
Roche Completes Acquisition of BioVeris
Roche Diagnostics now owns the patents for Electrochemiluminescence technology and can expand its immunochemistry into new market segments.
Substance in Tree Bark Could Lead to new Lung-Cancer Treatment
UT Southwestern researchers determined how a substance derived from the bark of the South American lapacho tree kills certain kinds of cancer cells.
Weill Cornell Medical College Team Identifies Potential new Cancer Drug Target
Weill Cornell researchers have uncovered two new potential points of vulnerability on a key cancer-promoting protein, called XIAP.
Abraxis BioScience Signs Licensing Agreement with University of Southern California
Abraxis exclusively licenses property portfolio designed to personalize treatment for colorectal cancer from the University of Southern California.
Study Suggests Breast Cancer Drug may Protect Heart
Duke researchers have opened up a new way to screen drugs for possible heart-related side effects and to develop new drugs.
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
The extended agreement allows Abbott to retain exclusive rights to 10 targets in lung cancer identified by Caprion for up to two years.
QIAGEN and Digene Announce Merger Agreement
QIAGEN and Digene have announced a definitive agreement to combine the two companies to create market- and technology-leadership in molecular diagnostics.
Helmholtz Initiative on Systems Biology
The long-term goal of the initiative is to shed light on the causes of complex disorders and diseases and develop new approaches for treating them.
Bristol-Myers Squibb Awards Immunicon Research Services Agreement for Oncology Biomarker Development
The research agreement between Immunicon and Bristol-Myers Squibb involve protein and molecular targets associated with circulating tumor cells.